Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT06985758
What this trial is testing

Pharmacokinetic Study of Rezafungin in Patients With Suspected Intra-Abdominal Candidiasis

Who this might be right for
Candidal Peritonitis
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 20
Early research (Phase 1)Study completedNCT01887626
What this trial is testing

Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.

Who this might be right for
Bioavailability Heathy Volunteers
AstraZeneca 36
Large-scale testing (Phase 3)Study completedNCT03009526
What this trial is testing

Efficacy and Safety of IPTp-DP Versus IPTp-SP in Malawi

Who this might be right for
MalariaPregnancy
Kamuzu University of Health Sciences 602
Early research (Phase 1)Study completedNCT00962026
What this trial is testing

Rilonacept in Diabetes Mellitus Type 1: Safety Study

Who this might be right for
Type 1 Diabetes Mellitus
University of Texas Southwestern Medical Center 13
Early research (Phase 1)Study completedNCT02835508
What this trial is testing

Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 18
Testing effectiveness (Phase 2)Looking for participantsNCT07287150
What this trial is testing

Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Hoffmann-La Roche 100
Not applicableApproved For MarketingNCT01160250
What this trial is testing

Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Who this might be right for
Basal Cell Carcinoma
Genentech, Inc.
Testing effectiveness (Phase 2)Study completedNCT01532518
What this trial is testing

Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance

Who this might be right for
Colic
Menarini Group 27
Early research (Phase 1)Study completedNCT05099510
What this trial is testing

Safety and Pharmacokinetics (PK) Study of Natrunix in Healthy Volunteers

Who this might be right for
Pharmacokinetics
XBiotech, Inc. 24
Early research (Phase 1)Study completedNCT02018510
What this trial is testing

A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117

Who this might be right for
HealthyHIV
Rockefeller University 49
Testing effectiveness (Phase 2)Study completedNCT00869713
What this trial is testing

Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated

Who this might be right for
Rift Valley Fever
U.S. Army Medical Research and Development Command 98
Large-scale testing (Phase 3)Ended earlyNCT00907413
What this trial is testing

Photodynamic Therapy (PDT) Trial for Palliation of Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Weill Medical College of Cornell University 50
Large-scale testing (Phase 3)Ended earlyNCT01295060
What this trial is testing

Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly

Who this might be right for
Acromegaly
Endo USA Inc., a Keenova Therapeutics Company 12
Large-scale testing (Phase 3)Study completedNCT00981682
What this trial is testing

Long Term Safety Assessment of SER120 in Patients With Nocturia

Who this might be right for
Nocturia
Serenity Pharmaceuticals, Inc. 376
Early research (Phase 1)Study completedNCT01139723
What this trial is testing

The Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors

Who this might be right for
Solid Cancers
Genentech, Inc. 54
Early research (Phase 1)Study completedNCT01611623
What this trial is testing

Safety and Pharmacology Study of SNX-5422 in Subjects With Refractory Solid Tumor Malignancies

Who this might be right for
Cancer
Esanex Inc. 9
Large-scale testing (Phase 3)Study completedNCT00059280
What this trial is testing

The Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease

Who this might be right for
Glycogen Storage Disease Type II
Genzyme, a Sanofi Company 16
Large-scale testing (Phase 3)Study completedNCT00835380
What this trial is testing

2 Doses of VAQTA™ in Healthy Children 12 to 23 Months of Age (V251-069)

Who this might be right for
Hepatitis A Virus Infection
Merck Sharp & Dohme LLC 80
Early research (Phase 1)Study completedNCT07543276
What this trial is testing

Pharmacokinetic (PK) Evaluation of Nalmefene Formulations

Who this might be right for
Opioid Overdose
Knoa Pharma LLC 13
Early research (Phase 1)Study completedNCT01613976
What this trial is testing

A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients

Who this might be right for
Myelodysplastic Syndromes (MDS)Chronic Myelomonocytic Leukemia (CMML)Acute Myeloid Leukemia (AML)
Novartis Pharmaceuticals 10
Next Page